(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MEDSTUDIO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MEDSTUDIO

ST13

US500000087211253

Class

41, 44

Filing

87211253

Registration

5376416

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

06/08/2024

Trademark type

Word

Nice classes

41, 44

Filing date

10/21/2016

Registration date

01/09/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/08/2024

Last transaction

06/08/2024

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/01/2017

First use in commerce

03/01/2017

Drawing code

4

Owner type

16

Owner location

Minneapolis, MN, US

Examiner

MCMORROW, JANICE LEE

Current location

Historical data usage

Holders and representatives

Holders

MedStudio, LLC

Representatives

Todd R. Fronek LARKIN HOFFMAN DALY & LINDGREN LTD.

Technical classification

Nice Classes

Class 41Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 41

Health and lifestyle coaching in the field of natural health therapies

Class 44

Medical clinic providing natural therapiesnatural hormone therapyweight loss solutionsskin care and aesthetic proceduresmigraine relief; medical testing for diagnostic or treatment purposes; vitamin therapy; massage; aromatherapy services

Publications

History of USPTO decisions and trademark events.

32 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

06/08/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/08/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/08/2024

E815

TEAS SECTION 8 & 15 RECEIVED

12/04/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/09/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

01/09/2018

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/05/2017

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/04/2017

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/29/2017

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/29/2017

IUAF

USE AMENDMENT FILED

11/14/2017

EISU

TEAS STATEMENT OF USE RECEIVED

11/14/2017

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/23/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/28/2017

PUBO

PUBLISHED FOR OPPOSITION

03/28/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/08/2017

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/22/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/15/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/15/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/15/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/06/2017

CEPE

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED

02/06/2017

ALIE

ASSIGNED TO LIE

02/06/2017

GEAN

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

02/06/2017

GEAP

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

02/06/2017

CPEA

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

02/06/2017

DOCK

ASSIGNED TO EXAMINER

01/31/2017

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/14/2016

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/14/2016

MPMK

NOTICE OF PSEUDO MARK E-MAILED

10/27/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/26/2016

NWAP

NEW APPLICATION ENTERED

10/25/2016

Continuous trademark protection

Get notified about every new filing that threatens MEDSTUDIO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.